Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-08 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0004 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |